Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

PODCAST: A CBD-focused First-to-Market Franchise Model

This podcast is part of our Cannabis Sector CEO interview series. The focus of our new StockTalk Podcasts is to help listeners and investors learn about, understand, and discover investment opportunities in the public marketplace.   Stockhouse Media's Dave Jackson was r...
Dave Jackson | September 19, 2019 |

Odd Burger, disrupting the fast food industry

Odd Burger (TSXV:ODD) is on a mission to disrupt the conventional fast food industry. The Ontario-based, entirely vegan company produces fast food made from scratch using plant-based, minimally processed and sustainable ingredients and also has nine restaurant locatio...
Simon Druker | July 4, 2023 |

Forging a New Path into the Medical Cannabis Space

Although 2019 was in many ways ‘The Year that the Cannabis Sector Would Like to Forget’, there are many pioneering ways that a company can take to generate revenue in the still-emerging medical cannabis and CBD markets. One such company has been advancing st...
Dave Jackson | February 13, 2020 |

New Listing & Already Profitable? How This Gaming Company is Capturing the Market

(Image via PopReach) The video game market has gone from an entertainment afterthought in the 2000’s to the largest media market in the world. But what’s the best way for investors to play in the space? Many instinctively look to th...
Stockhouse Editorial | July 8, 2020 |

E*TRADE Shares Rise 23% on $13 Billion Acquisition by Morgan Stanley

Shares of E*TRADE Financial Corp. reached a new 52-week intraday high price on news that the company entered into a definitive agreement to be acquired by Morgan Stanley for $13 billion in an all stock deal. Early this morning prior to the U.S. markets open,...
Streetwise Reports | February 21, 2020 |

Coverage Initiated on 'Biotech Machine'

The compelling reasons behind those descriptors are explored in a Dawson James Securities report. In an Aug. 26 research note, analyst Jason Kolbert reported that DawsonJames Securities initiated coverage on Fortress Biotech Inc. (FBIO:NASDAQ) with a Buy rating and ...
Streetwise Reports | September 5, 2019 |

Avedro Shares Looking Up 35% with Glaukos Merger

Avedro Inc. and Glaukos Corp. announced that the firms' boards of directors have executed a definitive merger agreement. The all-stock deal is expected to close in Q4/19. After the markets closed yesterday afternoon, corneal modeling platform firm Avedro Inc...
Streetwise Reports | August 13, 2019 |

This Unique App “Matches the Perfect Customer to the Ideal Vehicle”

Negotiating a new vehicle purchase is often an exercise in futility and sometimes ends in frustration. Now, there’s a Canadian company that’s offering a unique new app that makes the entire purchase and financing easy. How? By bringing the ve...
Dave Jackson | May 2, 2022 |

Coverage Initiated on U.S.-Based Precision Therapy Developer

The key reasons this story is compelling are given in an H.C. Wainwright & Co. report. In an Oct. 3 research note, analyst Andrew Fein reported that H.C. Wainwright & Co. initiated coverage on Blueprint Medicines Corp. (BPMC:NASDAQ) with a Buy rating and a $100 per ...
Streetwise Reports | October 9, 2019 |

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...
Streetwise Reports | January 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...